Prioritizing treatment attributes and their impact on selecting an oral triptan

results from the TRIPSTAR Project.

David W. Dodick, Richard B. Lipton, Michel D. Ferrari, Peter J. Goadsby, Douglas McCrory, F. Michael Cutrer, Paul Williams

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Seven oral triptans, which differ on a range of attributes important for treatment selection, are now available for treating migraine. US neurologists were surveyed to assess the relative importance of treatment attributes, prespecified by clinical relevance and availability of controlled study data, for selecting among oral triptans. Using a multiattribute decision model, we combined these data on the importance of treatment attributes with information on the relative performance of the oral triptans derived from a recent meta-analysis of controlled clinical trials.

Original languageEnglish (US)
Pages (from-to)435-442
Number of pages8
JournalCurrent Pain and Headache Reports
Volume8
Issue number6
StatePublished - Dec 2004
Externally publishedYes

Fingerprint

Tryptamines
Controlled Clinical Trials
Migraine Disorders
Meta-Analysis
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Dodick, D. W., Lipton, R. B., Ferrari, M. D., Goadsby, P. J., McCrory, D., Cutrer, F. M., & Williams, P. (2004). Prioritizing treatment attributes and their impact on selecting an oral triptan: results from the TRIPSTAR Project. Current Pain and Headache Reports, 8(6), 435-442.

Prioritizing treatment attributes and their impact on selecting an oral triptan : results from the TRIPSTAR Project. / Dodick, David W.; Lipton, Richard B.; Ferrari, Michel D.; Goadsby, Peter J.; McCrory, Douglas; Cutrer, F. Michael; Williams, Paul.

In: Current Pain and Headache Reports, Vol. 8, No. 6, 12.2004, p. 435-442.

Research output: Contribution to journalArticle

Dodick, DW, Lipton, RB, Ferrari, MD, Goadsby, PJ, McCrory, D, Cutrer, FM & Williams, P 2004, 'Prioritizing treatment attributes and their impact on selecting an oral triptan: results from the TRIPSTAR Project.', Current Pain and Headache Reports, vol. 8, no. 6, pp. 435-442.
Dodick, David W. ; Lipton, Richard B. ; Ferrari, Michel D. ; Goadsby, Peter J. ; McCrory, Douglas ; Cutrer, F. Michael ; Williams, Paul. / Prioritizing treatment attributes and their impact on selecting an oral triptan : results from the TRIPSTAR Project. In: Current Pain and Headache Reports. 2004 ; Vol. 8, No. 6. pp. 435-442.
@article{ae96622f7fbf404cb6070c89da95b733,
title = "Prioritizing treatment attributes and their impact on selecting an oral triptan: results from the TRIPSTAR Project.",
abstract = "Seven oral triptans, which differ on a range of attributes important for treatment selection, are now available for treating migraine. US neurologists were surveyed to assess the relative importance of treatment attributes, prespecified by clinical relevance and availability of controlled study data, for selecting among oral triptans. Using a multiattribute decision model, we combined these data on the importance of treatment attributes with information on the relative performance of the oral triptans derived from a recent meta-analysis of controlled clinical trials.",
author = "Dodick, {David W.} and Lipton, {Richard B.} and Ferrari, {Michel D.} and Goadsby, {Peter J.} and Douglas McCrory and Cutrer, {F. Michael} and Paul Williams",
year = "2004",
month = "12",
language = "English (US)",
volume = "8",
pages = "435--442",
journal = "Current Pain and Headache Reports",
issn = "1531-3433",
publisher = "Current Science, Inc.",
number = "6",

}

TY - JOUR

T1 - Prioritizing treatment attributes and their impact on selecting an oral triptan

T2 - results from the TRIPSTAR Project.

AU - Dodick, David W.

AU - Lipton, Richard B.

AU - Ferrari, Michel D.

AU - Goadsby, Peter J.

AU - McCrory, Douglas

AU - Cutrer, F. Michael

AU - Williams, Paul

PY - 2004/12

Y1 - 2004/12

N2 - Seven oral triptans, which differ on a range of attributes important for treatment selection, are now available for treating migraine. US neurologists were surveyed to assess the relative importance of treatment attributes, prespecified by clinical relevance and availability of controlled study data, for selecting among oral triptans. Using a multiattribute decision model, we combined these data on the importance of treatment attributes with information on the relative performance of the oral triptans derived from a recent meta-analysis of controlled clinical trials.

AB - Seven oral triptans, which differ on a range of attributes important for treatment selection, are now available for treating migraine. US neurologists were surveyed to assess the relative importance of treatment attributes, prespecified by clinical relevance and availability of controlled study data, for selecting among oral triptans. Using a multiattribute decision model, we combined these data on the importance of treatment attributes with information on the relative performance of the oral triptans derived from a recent meta-analysis of controlled clinical trials.

UR - http://www.scopus.com/inward/record.url?scp=16544394399&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=16544394399&partnerID=8YFLogxK

M3 - Article

VL - 8

SP - 435

EP - 442

JO - Current Pain and Headache Reports

JF - Current Pain and Headache Reports

SN - 1531-3433

IS - 6

ER -